Data search
Results for MligTC455_23142
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_23142 | 769 | 16.02 | Mlig455_008044 | Neo: - Age: - |
INSR | Mlig455_008044 {REF} {Length: 5353} {TRANSSPLICED} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=291.8]; Protein kinase domain [PF00069.27, score=128.4]; Receptor L domain [PF01030.26, score=118.4]; Furin-like cysteine rich region [PF00757.22, score=79.0]; Fibronectin type III domain [PF00041.23, score=45.0]; Growth factor receptor domain IV [PF14843.8, score=19.9]} {Human: ENSG00000171105, INSR, insulin receptor, [RH, Score=647, Expect=0.0]} {Mouse: ENSMUSG00000005534, Insr, insulin receptor, [RH, Score=643, Expect=0.0]} {Dmel: FBgn0283499, InR, Insulin-like receptor, [RH, Score=333, Expect=8e-93]} {Celegans: WBGene00000898, daf-2, Insulin-like receptor Insulin-like receptor subunit alpha Insulin-like receptor subunit beta, [RH, Score=474, Expect=3e-140]} {Smed: dd_Smed_v6_9006_0_1, dd_Smed_v6_9006_0_1, [RH, Score=514, Expect=3e-157]} {RNA1509_5152} {RNA1310_762.1} {RNA815_285.1} |
Cumulative graph for MligTC455_23142
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -0.892 | 4.234 | 0.51897 | 1.00000 | |
| RegionR2 | 1.005 | 4.234 | 0.01879 | 0.14710 | |
| RegionR3 | -0.441 | 4.234 | 0.26665 | 0.81082 | |
| RegionR4 | -0.82 | 4.234 | 0.07981 | 0.26447 | |
| RegionR5 | 0.449 | 4.234 | 0.14592 | 0.39563 | |
| RegionR6 | -0.334 | 4.234 | 0.40362 | 0.97431 | |
| RegionR7 | 0.868 | 4.234 | 0.06063 | 0.47229 | |
| RegionR8 | 0.166 | 4.234 | 0.81339 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 0.832 | 4.234 | 0.62507 | 1.00000 | |
| RegenerationR2 | 0.372 | 4.234 | 0.17215 | 0.61182 | |
| RegenerationR3 | 0.43 | 4.234 | 0.24774 | 0.68172 | |
| RegenerationR4 | 0.129 | 4.234 | 0.73718 | 0.96675 | |
| RegenerationR5 | -0.151 | 4.234 | 0.61831 | 0.91791 | |
| RegenerationR6 | 0.622 | 4.234 | 0.08861 | 0.37140 | |
| RegenerationBL | -0.021 | 4.234 | 0.96249 | 1.00000 | |
| RegenerationTP | -0.845 | 4.234 | 0.14020 | 0.55850 |
Genes with expression patterns similar to MligTC455_23142
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_23142 | 769 | 16.02 | Mlig455_008044 | Neo: - Age: - |
INSR | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_008044 {REF} {Length: 5353} {TRANSSPLICED} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=291.8]; Protein kinase domain [PF00069.27, score=128.4]; Receptor L domain [PF01030.26, score=118.4]; Furin-like cysteine rich region [PF00757.22, score=79.0]; Fibronectin type III domain [PF00041.23, score=45.0]; Growth factor receptor domain IV [PF14843.8, score=19.9]} {Human: ENSG00000171105, INSR, insulin receptor, [RH, Score=647, Expect=0.0]} {Mouse: ENSMUSG00000005534, Insr, insulin receptor, [RH, Score=643, Expect=0.0]} {Dmel: FBgn0283499, InR, Insulin-like receptor, [RH, Score=333, Expect=8e-93]} {Celegans: WBGene00000898, daf-2, Insulin-like receptor Insulin-like receptor subunit alpha Insulin-like receptor subunit beta, [RH, Score=474, Expect=3e-140]} {Smed: dd_Smed_v6_9006_0_1, dd_Smed_v6_9006_0_1, [RH, Score=514, Expect=3e-157]} {RNA1509_5152} {RNA1310_762.1} {RNA815_285.1} |
| 2. | MligTC455_23143 | 413 | 8.6 | Mlig455_008087 | Neo: - Age: - Region-enriched R2: 2.201/0.04155 |
INSR | 4.323 | 0.868 | 0.807 | 0.789 | - | 0.972 | 0.887 | Mlig455_008087 {REF} {Length: 5415} {TRANSSPLICED} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=291.7]; Protein kinase domain [PF00069.27, score=128.3]; Receptor L domain [PF01030.26, score=118.3]; Furin-like cysteine rich region [PF00757.22, score=79.0]; Fibronectin type III domain [PF00041.23, score=43.3]; Growth factor receptor domain IV [PF14843.8, score=19.7]} {Human: ENSG00000171105, INSR, insulin receptor, [RH, Score=647, Expect=0.0]} {Mouse: ENSMUSG00000005534, Insr, insulin receptor, [RH, Score=643, Expect=0.0]} {Dmel: FBgn0283499, InR, Insulin-like receptor, [RH, Score=333, Expect=9e-93]} {Celegans: WBGene00000898, daf-2, Insulin-like receptor Insulin-like receptor subunit alpha Insulin-like receptor subunit beta, [RH, Score=477, Expect=6e-141]} {Smed: dd_Smed_v6_9006_0_1, dd_Smed_v6_9006_0_1, [RH, Score=516, Expect=7e-158]} {RNA1509_32205, RNA1509_5152} {RNA1310_762.1, RNA1509_32205, RNA1509_5152} {RNA1509_32205, RNA1509_5152, RNA815_285.1} |
| 3. | MligTC455_23141 | 252 | 5.24 | Mlig455_007944 | Neo: - Age: Up-Down-Up |
INSR | 2.727 | - | - | 0.914 | - | 0.961 | 0.852 | Mlig455_007944 {REF} {Length: 7081} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=291.8]; Protein kinase domain [PF00069.27, score=128.4]; Receptor L domain [PF01030.26, score=118.3]; Furin-like cysteine rich region [PF00757.22, score=79.0]; Fibronectin type III domain [PF00041.23, score=43.4]; Growth factor receptor domain IV [PF14843.8, score=19.7]} {Human: ENSG00000171105, INSR, insulin receptor, [RH, Score=647, Expect=0.0]} {Mouse: ENSMUSG00000005534, Insr, insulin receptor, [RH, Score=641, Expect=0.0]} {Dmel: FBgn0283499, InR, Insulin-like receptor, [RH, Score=334, Expect=6e-93]} {Celegans: WBGene00000898, daf-2, Insulin-like receptor Insulin-like receptor subunit alpha Insulin-like receptor subunit beta, [RH, Score=474, Expect=4e-140]} {Smed: dd_Smed_v6_9006_0_1, dd_Smed_v6_9006_0_1, [RH, Score=516, Expect=4e-158]} {RNA1509_5152} {RNA1310_762.1} {RNA815_285.1} |
| 4. | MligTC455_45202 | 245 | 5.09 | Mlig455_024626 | Neo: - Age: Up-Down-Up |
DLG5 | 2.612 | - | 0.814 | 0.829 | - | 0.969 | - | Mlig455_024626 {REF} {Length: 7074} {Pfam: PDZ domain [PF00595.26, score=126.1]; PDZ domain [PF17820.3, score=97.9]; PDZ domain [PF13180.8, score=52.9]} {Human: ENSG00000151208, DLG5, discs large MAGUK scaffold protein 5, [RH, Score=213, Expect=3e-56]; ENSG00000274429, DLG5, discs large MAGUK scaffold protein 5, [RH, Score=213, Expect=3e-56]} {Mouse: ENSMUSG00000021782, Dlg5, discs large MAGUK scaffold protein 5, [RH, Score=204, Expect=2e-52]} {Dmel: FBgn0032363, Dlg5, Discs large 5, [Score=147, Expect=3e-35]} {Celegans: WBGene00013683, zoo-1, ZO-1 (Zonula Occludens tight junctional protein) Ortholog, [Score=65.5, Expect=3e-10]} {RNA1509_10377} {RNA1310_678} {RNA815_15135} |
| 5. | MligTC455_40125 | 953 | 19.86 | Mlig455_005600, Mlig455_014458 | Neo: - Age: Up-Down-Down |
KIF13B, KIF1B | 2.591 | - | - | - | 0.952 | 0.814 | 0.825 | Mlig455_005600 {REF} {Length: 4684} {Pfam: Kinesin protein 1B [PF12423.10, score=42.5]} {Human: ENSG00000197892, KIF13B, kinesin family member 13B, [Score=61.6, Expect=2e-09]} {Mouse: ENSMUSG00000087236, Kif28, kinesin family member 28, [Score=98.2, Expect=4e-21]} {Dmel: FBgn0019968, Khc-73, Kinesin heavy chain 73, [Score=57.0, Expect=3e-08]} {Celegans: WBGene00002218, klp-6, Kinesin-like protein, [Score=177, Expect=5e-48]} {Smed: dd_Smed_v6_20223_0_1, dd_Smed_v6_20223_0_1, [Score=118, Expect=3e-28]} {RNA1509_6760} {RNA1310_2628} {RNA815_4402} Mlig455_014458 {REF} {Length: 3819} {Pfam: Kinesin motor domain [PF00225.25, score=336.4]; Microtubule binding [PF16796.7, score=68.9]; Kinesin protein 1B [PF12423.10, score=40.0]; Kinesin-associated [PF16183.7, score=27.3]} {Human: ENSG00000054523, KIF1B, kinesin family member 1B, [Score=404, Expect=2e-123]; ENSG00000137177, KIF13A, kinesin family member 13A, [Score=404, Expect=9e-120]; ENSG00000130294, KIF1A, kinesin family member 1A, [Score=404, Expect=2e-120]; ENSG00000197892, KIF13B, kinesin family member 13B, [Score=399, Expect=2e-125]; ENSG00000129250, KIF1C, kinesin family member 1C, [Score=398, Expect=2e-121]} {Mouse: ENSMUSG00000087236, Kif28, kinesin family member 28, [Score=568, Expect=0.0]} {Dmel: FBgn0019968, Khc-73, Kinesin heavy chain 73, [Score=415, Expect=5e-124]} {Celegans: WBGene00002218, klp-6, Kinesin-like protein, [RH, Score=818, Expect=0.0]} {Smed: dd_Smed_v6_12573_0_1, dd_Smed_v6_12573_0_1, [Score=617, Expect=0.0]} {RNA1509_6760} {RNA1310_1667.1} {RNA815_1144} |
| 6. | MligTC455_45201 | 166 | 3.46 | Mlig455_024614 | Neo: - Age: - |
DLG5 | 2.542 | - | - | 0.817 | - | 0.951 | 0.774 | Mlig455_024614 {REF} {Length: 9018} {Pfam: PDZ domain [PF00595.26, score=124.9]; PDZ domain [PF17820.3, score=96.7]; PDZ domain [PF13180.8, score=51.9]} {Human: ENSG00000151208, DLG5, discs large MAGUK scaffold protein 5, [RH, Score=234, Expect=2e-61]; ENSG00000274429, DLG5, discs large MAGUK scaffold protein 5, [RH, Score=234, Expect=2e-61]} {Mouse: ENSMUSG00000021782, Dlg5, discs large MAGUK scaffold protein 5, [RH, Score=221, Expect=2e-57]} {Dmel: FBgn0032363, Dlg5, Discs large 5, [RH, Score=162, Expect=1e-39]} {Celegans: WBGene00013683, zoo-1, ZO-1 (Zonula Occludens tight junctional protein) Ortholog, [Score=75.5, Expect=3e-13]} {Smed: dd_Smed_v6_7374_0_1, dd_Smed_v6_7374_0_1, [Score=55.5, Expect=3e-07]} {RNA1509_10377} {RNA1310_678} {RNA815_15135} |
| 7. | MligTC455_46568 | 2971 | 61.9 | Mlig455_023525, Mlig455_023630 | Neo: - Age: logFC(26M/2M)=0.378 Region-enriched R2: 1.180/0.03735 |
GNB2 | 1.883 | - | - | - | 0.957 | 0.926 | - | Mlig455_023525 {REF} {Length: 2676} {TRANSSPLICED} {Pfam: WD domain, G-beta repeat [PF00400.34, score=144.6]; Anaphase-promoting complex subunit 4 WD40 domain [PF12894.9, score=48.6]; WD40-like domain [PF17005.7, score=18.1]; WD40 region of Ge1, enhancer of mRNA-decapping protein [PF16529.7, score=17.9]} {Human: ENSG00000172354, GNB2, G protein subunit beta 2, [RH, Score=602, Expect=0.0]; ENSG00000114450, GNB4, G protein subunit beta 4, [RH, Score=601, Expect=0.0]; ENSG00000078369, GNB1, G protein subunit beta 1, [RH, Score=595, Expect=0.0]; ENSG00000111664, GNB3, G protein subunit beta 3, [RH, Score=581, Expect=0.0]} {Mouse: ENSMUSG00000029713, Gnb2, guanine nucleotide binding protein (G protein), beta 2, [RH, Score=602, Expect=0.0]; ENSMUSG00000029064, Gnb1, guanine nucleotide binding protein (G protein), beta 1, [RH, Score=595, Expect=0.0]; ENSMUSG00000023439, Gnb3, guanine nucleotide binding protein (G protein), beta 3, [RH, Score=581, Expect=0.0]; ENSMUSG00000027669, Gnb4, guanine nucleotide binding protein (G protein), beta 4, [RH, Score=572, Expect=0.0]} {Dmel: FBgn0001105, Gbeta13F, G protein beta-subunit 13F, [RH, Score=611, Expect=0.0]} {Celegans: WBGene00001679, gpb-1, Guanine nucleotide-binding protein subunit beta-1, [RH, Score=637, Expect=0.0]} {Smed: dd_Smed_v6_1184_0_1, dd_Smed_v6_1184_0_1, [RH, Score=649, Expect=0.0]} {RNA1509_23211} {RNA1310_7177.1} {RNA815_1953.1} Mlig455_023630 {REF} {Length: 2694} {TRANSSPLICED} {Pfam: WD domain, G-beta repeat [PF00400.34, score=144.6]; Anaphase-promoting complex subunit 4 WD40 domain [PF12894.9, score=48.6]; WD40-like domain [PF17005.7, score=18.1]; WD40 region of Ge1, enhancer of mRNA-decapping protein [PF16529.7, score=17.9]} {Human: ENSG00000172354, GNB2, G protein subunit beta 2, [RH, Score=602, Expect=0.0]; ENSG00000114450, GNB4, G protein subunit beta 4, [RH, Score=601, Expect=0.0]; ENSG00000078369, GNB1, G protein subunit beta 1, [RH, Score=595, Expect=0.0]; ENSG00000111664, GNB3, G protein subunit beta 3, [RH, Score=581, Expect=0.0]} {Mouse: ENSMUSG00000029713, Gnb2, guanine nucleotide binding protein (G protein), beta 2, [RH, Score=602, Expect=0.0]; ENSMUSG00000029064, Gnb1, guanine nucleotide binding protein (G protein), beta 1, [RH, Score=595, Expect=0.0]; ENSMUSG00000023439, Gnb3, guanine nucleotide binding protein (G protein), beta 3, [RH, Score=581, Expect=0.0]; ENSMUSG00000027669, Gnb4, guanine nucleotide binding protein (G protein), beta 4, [RH, Score=572, Expect=0.0]} {Dmel: FBgn0001105, Gbeta13F, G protein beta-subunit 13F, [RH, Score=611, Expect=0.0]} {Celegans: WBGene00001679, gpb-1, Guanine nucleotide-binding protein subunit beta-1, [RH, Score=637, Expect=0.0]} {Smed: dd_Smed_v6_1184_0_1, dd_Smed_v6_1184_0_1, [RH, Score=649, Expect=0.0]} {RNA1509_5140} {RNA1310_7177.1} {RNA815_1953.1} |
| 8. | MligTC455_51779 | 660 | 13.75 | Mlig455_031396 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.441/0.00016 |
CACNA1C | 1.876 | - | - | - | 0.977 | 0.899 | - | Mlig455_031396 {REF} {Length: 8157} {Pfam: Ion transport protein [PF00520.33, score=797.6]; Voltage gated calcium channel IQ domain [PF08763.13, score=101.0]; Voltage-dependent L-type calcium channel, IQ-associated [PF16905.7, score=100.3]; Polycystin cation channel [PF08016.14, score=31.5]} {Human: ENSG00000151067, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1289, Expect=0.0]; ENSG00000285479, CACNA1C, calcium voltage-gated channel subunit alpha1 C, [Score=1289, Expect=0.0]; ENSG00000157388, CACNA1D, calcium voltage-gated channel subunit alpha1 D, [Score=1286, Expect=0.0]; ENSG00000081248, CACNA1S, calcium voltage-gated channel subunit alpha1 S, [Score=1273, Expect=0.0]} {Mouse: ENSMUSG00000051331, Cacna1c, calcium channel, voltage-dependent, L type, alpha 1C subunit, [Score=1294, Expect=0.0]; ENSMUSG00000015968, Cacna1d, calcium channel, voltage-dependent, L type, alpha 1D subunit, [Score=1288, Expect=0.0]; ENSMUSG00000031142, Cacna1f, calcium channel, voltage-dependent, alpha 1F subunit, [Score=1276, Expect=0.0]; ENSMUSG00000026407, Cacna1s, calcium channel, voltage-dependent, L type, alpha 1S subunit, [Score=1260, Expect=0.0]} {Dmel: FBgn0001991, Ca-alpha1D, Ca[2+]-channel protein alpha[[1]] subunit D, [Score=1292, Expect=0.0]} {Celegans: WBGene00006742, unc-2, High voltage activated calcium channel alpha-1 subunit, [RH, Score=1690, Expect=0.0]} {Smed: dd_Smed_v6_13295_0_1, dd_Smed_v6_13295_0_1, [RH, Score=2129, Expect=0.0]} {RNA1509_11510} {RNA1310_2184.1} {RNA815_2606} |
| 9. | MligTC455_11473 | 248 | 5.17 | Mlig455_009711, Mlig455_071036 | Neo: - Age: Down-Up-Down |
CHRNA3 | 1.861 | - | - | - | 0.988 | 0.873 | - | Mlig455_009711 {REF} {Length: 2402} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=241.4]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.9]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=391, Expect=2e-130]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=379, Expect=6e-126]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=375, Expect=2e-124]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=390, Expect=2e-130]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=375, Expect=2e-124]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [RH, Score=499, Expect=9e-173]} {Celegans: WBGene00000043, acr-3, Acetylcholine receptor subunit beta-type acr-3, [RH, Score=426, Expect=6e-145]} {Smed: dd_Smed_v6_12146_0_1, dd_Smed_v6_12146_0_1, [Score=510, Expect=1e-176]} {RNA1509_48201} {RNA1310_10118} {RNA815_29940} Mlig455_071036 {REF} {Length: 746} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.1]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [Score=63.5, Expect=2e-13]} {Celegans: WBGene00000042, acr-2, Acetylcholine receptor subunit beta-type acr-2, [Score=63.9, Expect=9e-14]} {Smed: dd_Smed_v6_12535_0_1, dd_Smed_v6_12535_0_1, [Score=64.3, Expect=6e-14]} {RNA1310_21182} {RNA815_29940} |
| 10. | MligTC455_35063 | 359 | 7.49 | Mlig455_017090 | Neo: - Age: logFC(26M/2M)=-0.336 Region-enriched R2: 2.861/0.00814 |
DNM1 | 1.858 | - | - | - | 0.965 | 0.893 | - | Mlig455_017090 {REF} {Length: 4208} {Pfam: Dynamin central region [PF01031.22, score=334.5]; Dynamin family [PF00350.25, score=184.2]; Dynamin GTPase effector domain [PF02212.20, score=80.3]; PH domain [PF00169.31, score=37.3]; 50S ribosome-binding GTPase [PF01926.25, score=21.3]} {Human: ENSG00000106976, DNM1, dynamin 1, [RH, Score=1101, Expect=0.0]; ENSG00000197959, DNM3, dynamin 3, [RH, Score=1094, Expect=0.0]; ENSG00000079805, DNM2, dynamin 2, [RH, Score=1075, Expect=0.0]} {Mouse: ENSMUSG00000026825, Dnm1, dynamin 1, [RH, Score=1102, Expect=0.0]; ENSMUSG00000040265, Dnm3, dynamin 3, [RH, Score=1089, Expect=0.0]; ENSMUSG00000033335, Dnm2, dynamin 2, [RH, Score=1074, Expect=0.0]} {Dmel: FBgn0003392, shi, shibire, [RH, Score=1074, Expect=0.0]} {Celegans: WBGene00001130, dyn-1, Dynamin, [RH, Score=984, Expect=0.0]} {Smed: dd_Smed_v6_6863_0_1, dd_Smed_v6_6863_0_1, [RH, Score=1068, Expect=0.0]} {RNA1509_31451, RNA1509_50695} {RNA1310_8903.1, RNA1509_31451, RNA1509_50695} {RNA1509_31451, RNA1509_50695, RNA815_1703.1} |
| 11. | MligTC455_32624 | 513 | 10.69 | Mlig455_049590 | Neo: - Age: - Region-enriched R2: 2.722/0.00305 |
1.831 | - | - | - | 0.953 | 0.878 | - | Mlig455_049590 {REF} {Length: 2947} {Smed: dd_Smed_v6_7527_0_1, dd_Smed_v6_7527_0_1, [RH, Score=84.0, Expect=5e-17]} {RNA1509_22587} {RNA1310_6575.1, RNA1509_22587} {RNA1509_22587, RNA815_5684.1} | |
| 12. | MligTC455_18122 | 1083 | 22.57 | Mlig455_020157 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.614 Region-specific R2: 4.994 Region-enriched R2: 4.087/0.00011 |
1.822 | - | - | - | 0.962 | 0.860 | - | Mlig455_020157 {REF} {Length: 2290} {RNA1310_56029} {RNA815_34539} | |
| 13. | MligTC455_45542 | 1297 | 27.03 | Mlig455_054862 | Neo: - Age: - Region-specific R2: 3.717 Region-enriched R2: 3.775/0.00000 |
1.778 | - | - | - | 0.961 | 0.817 | - | Mlig455_054862 {REF} {Length: 827} {RNA1509_22827, RNA1509_33579} {RNA1310_53394, RNA1509_22827, RNA1509_33579} {RNA1509_22827, RNA1509_33579, RNA815_31276} | |
| 14. | MligTC455_17473 | 91 | 1.9 | Mlig455_024742 | Neo: - Age: Up-Down-Up Region-enriched R6: 4.336/0.01880 |
1.767 | - | - | - | 0.974 | - | 0.793 | Mlig455_024742 {REF} {Length: 1023} {RNA1509_53854} {RNA1310_31915} {RNA815_45583} | |
| 15. | MligTC455_37682 | 225 | 4.68 | Mlig455_022978, Mlig455_023072 | Neo: - Age: Up-Down-Up Region-enriched R7: 2.657/0.03586 |
KCNN2 | 1.767 | - | - | - | - | 0.952 | 0.815 | Mlig455_022978 {REF} {Length: 4236} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.8]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=548, Expect=0.0]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=539, Expect=1e-180]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=549, Expect=0.0]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=541, Expect=0.0]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=637, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=424, Expect=5e-135]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1, RNA1509_28013} {RNA1509_28013, RNA815_7768} Mlig455_023072 {REF} {Length: 3426} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.0]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=534, Expect=3e-177]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=525, Expect=2e-175]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=536, Expect=1e-178]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=528, Expect=1e-176]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=627, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=410, Expect=8e-130]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=559, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_7768} |
| 16. | MligTC455_52446 | 827 | 17.23 | Mlig455_035295 | Neo: - Age: - |
GLS | 1.766 | - | - | 0.813 | 0.953 | - | - | Mlig455_035295 {REF} {Length: 3921} {TRANSSPLICED} {Pfam: Glutaminase [PF04960.17, score=391.6]; EF-hand domain [PF17959.3, score=65.7]; Ankyrin repeats (3 copies) [PF12796.9, score=41.9]; Ankyrin repeats (many copies) [PF13637.8, score=38.9]; Ankyrin repeat [PF00023.32, score=24.4]; Ankyrin repeat [PF13606.8, score=19.7]; Ankyrin repeats (many copies) [PF13857.8, score=18.9]} {Human: ENSG00000115419, GLS, glutaminase, [RH, Score=591, Expect=0.0]; ENSG00000135423, GLS2, glutaminase 2, [RH, Score=582, Expect=0.0]} {Mouse: ENSMUSG00000026103, Gls, glutaminase, [RH, Score=591, Expect=0.0]; ENSMUSG00000044005, Gls2, glutaminase 2 (liver, mitochondrial), [RH, Score=582, Expect=0.0]} {Dmel: FBgn0261625, GLS, Glutaminase, [RH, Score=612, Expect=0.0]} {Celegans: WBGene00008435, glna-2, Putative glutaminase 2, [RH, Score=554, Expect=0.0]} {Smed: dd_Smed_v6_15097_0_1, dd_Smed_v6_15097_0_1, [RH, Score=512, Expect=7e-178]} {RNA1509_46187, RNA1509_5599} {RNA1310_10945, RNA1509_46187, RNA1509_5599} {RNA1509_46187, RNA1509_5599, RNA815_3847.1} |
| 17. | MligTC455_51806 | 83 | 1.73 | Mlig455_037702, Mlig455_046362 | Neo: - Age: - |
GPSM2 | 1.755 | - | - | 0.798 | - | 0.957 | - | Mlig455_037702 {REF} {Length: 3216} {Pfam: Tetratricopeptide repeat [PF13424.8, score=100.7]; Tetratricopeptide repeat [PF13176.8, score=98.7]; Tetratricopeptide repeat [PF00515.30, score=93.3]; GoLoco motif [PF02188.19, score=66.5]; Tetratricopeptide repeat [PF07719.19, score=54.7]; Tetratricopeptide repeat [PF13181.8, score=43.2]; Tetratricopeptide repeat [PF13374.8, score=34.5]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.8]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=521, Expect=3e-176]} {Mouse: ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=494, Expect=2e-166]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=534, Expect=0.0]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [Score=256, Expect=4e-76]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=462, Expect=3e-154]} {RNA1310_18538} {RNA815_41322} Mlig455_046362 {REF} {Length: 3324} {Pfam: Tetratricopeptide repeat [PF13424.8, score=119.4]; Tetratricopeptide repeat [PF13176.8, score=96.3]; Tetratricopeptide repeat [PF00515.30, score=93.0]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=54.4]; Tetratricopeptide repeat [PF13181.8, score=42.7]; Tetratricopeptide repeat [PF13374.8, score=34.2]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=21.7]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [Score=545, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=535, Expect=0.0]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=531, Expect=1e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=1e-79]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=474, Expect=1e-158]} {RNA1310_18538} {RNA815_41322} |
| 18. | MligTC455_42963 | 247 | 5.15 | Mlig455_002825 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.597 Region-enriched R2: 5.687/0.00012 |
1.754 | - | - | - | 0.960 | 0.794 | - | Mlig455_002825 {REF} {Length: 726} {RNA1310_78982} {RNA815_41084} | |
| 19. | MligTC455_16247 | 405 | 8.43 | Mlig455_052011, Mlig455_057230 | Neo: - |
CXorf58 | 1.746 | - | 0.790 | - | - | - | 0.956 | Mlig455_052011 {REF} {Length: 2077} {Human: ENSG00000165182, CXorf58, chromosome X open reading frame 58, [RH, Score=192, Expect=4e-58]} {Mouse: ENSMUSG00000005131, 4930550C14Rik, RIKEN cDNA 4930550C14 gene, [Score=57.8, Expect=5e-09]} {Smed: dd_Smed_v6_8151_0_3, dd_Smed_v6_8151_0_3, [RH, Score=108, Expect=2e-27]} {RNA1509_41758} {RNA1310_19977} {RNA815_9459} Mlig455_057230 {REF} {Length: 3099} {Human: ENSG00000165182, CXorf58, chromosome X open reading frame 58, [RH, Score=194, Expect=9e-59]} {Mouse: ENSMUSG00000005131, 4930550C14Rik, RIKEN cDNA 4930550C14 gene, [Score=55.1, Expect=4e-08]} {Smed: dd_Smed_v6_8151_0_3, dd_Smed_v6_8151_0_3, [RH, Score=107, Expect=7e-27]} {RNA1509_41758} {RNA1310_19977} {RNA815_9459} |
| 20. | MligTC455_19845 | 602 | 12.53 | Mlig455_016261 | Neo: - Age: - Region-enriched R2: 2.356/0.00003 |
STOM | 1.744 | - | - | - | 0.976 | 0.768 | - | Mlig455_016261 {REF} {Length: 3265} {Pfam: SPFH domain / Band 7 family [PF01145.27, score=111.1]; SPFH domain-Band 7 family [PF13421.8, score=20.1]} {Human: ENSG00000148175, STOM, stomatin, [RH, Score=357, Expect=4e-124]} {Mouse: ENSMUSG00000026880, Stom, stomatin, [RH, Score=353, Expect=7e-123]} {Dmel: FBgn0260657, CG42540, [Score=359, Expect=8e-124]} {Celegans: WBGene00003166, mec-2, Mechanosensory protein 2, [RH, Score=384, Expect=1e-133]} {Smed: dd_Smed_v6_6396_0_1, dd_Smed_v6_6396_0_1, [RH, Score=426, Expect=7e-152]} {RNA1509_58645} {RNA1310_17679} {RNA815_7364.1} |
| 21. | MligTC455_17254 | 43 | 0.9 | Mlig455_020017 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.826/0.01049 |
1.732 | - | - | 0.771 | - | 0.961 | - | Mlig455_020017 {REF} {Length: 2272} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=24.5]} {Smed: dd_Smed_v6_42201_0_1, dd_Smed_v6_42201_0_1, [RH, Score=148, Expect=5e-41]} {RNA1310_19413.1} {RNA815_30978} | |
| 22. | MligTC455_50347 | 549 | 11.43 | Mlig455_012382 | Neo: - Age: Down-Up-Up Region-specific R2: 6.390 Region-enriched R2: 6.623/0.00000 |
1.729 | - | - | - | 0.951 | 0.778 | - | Mlig455_012382 {REF} {Length: 797} {RNA1509_48155} {RNA1310_70969.2, RNA1509_48155} {RNA1509_48155, RNA815_39712} | |
| 23. | MligTC455_16254 | 485 | 10.1 | Mlig455_039657 | Neo: - Age: Up-Down-Down |
1.719 | - | - | - | 0.963 | - | 0.756 | Mlig455_039657 {REF} {Length: 1117} {NoTransDecoderORF} {RNA1509_47868} {RNA1310_57969} {RNA815_28105} | |
| 24. | MligTC455_07053 | 23 | 0.47 | Mlig455_013671 | Neo: - Age: - |
1.711 | - | - | - | - | 0.972 | 0.739 | Mlig455_013671 {REF} {Length: 343} {RNA1509_19561} {RNA1310_8953} {RNA815_356.1} | |
| 25. | MligTC455_22509 | 603 | 12.56 | Mlig455_003867 | Neo: - Age: - Region-enriched R2: 1.712/0.01995 |
SLC7A4 | 1.67 | - | - | - | - | 0.961 | 0.709 | Mlig455_003867 {REF} {Length: 4423} {Pfam: Amino acid permease [PF13520.8, score=133.3]; Amino acid permease [PF00324.23, score=105.2]; C-terminus of AA_permease [PF13906.8, score=72.9]} {Human: ENSG00000099960, SLC7A4, solute carrier family 7 member 4, [RH, Score=400, Expect=1e-130]} {Mouse: ENSMUSG00000022756, Slc7a4, solute carrier family 7 (cationic amino acid transporter, y+ system), member 4, [RH, Score=422, Expect=2e-139]} {Dmel: FBgn0036984, CG13248, [RH, Score=458, Expect=5e-153]} {Celegans: WBGene00016806, C50D2.2, [RH, Score=416, Expect=1e-137]} {Smed: dd_Smed_v6_8652_0_2, dd_Smed_v6_8652_0_2, [Score=283, Expect=6e-87]} {RNA1509_13053, RNA1509_36328} {RNA1310_3004.1, RNA1509_13053, RNA1509_36328} {RNA1509_13053, RNA1509_36328, RNA815_1376} |
| 26. | MligTC455_47600 | 263 | 5.48 | Mlig455_031414 | Neo: - Age: - Region-enriched R2: 2.961/0.01561 |
NRXN1 | 1.665 | - | - | - | 0.959 | 0.706 | - | Mlig455_031414 {REF} {Length: 4843} {Pfam: Laminin G domain [PF02210.26, score=235.7]; Laminin G domain [PF00054.25, score=191.1]; Syndecan domain [PF01034.22, score=26.0]; Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=22.3]; EGF-like domain [PF00008.29, score=19.4]} {Human: ENSG00000179915, NRXN1, neurexin 1, [RH, Score=379, Expect=3e-109]} {Mouse: ENSMUSG00000024109, Nrxn1, neurexin I, [Score=387, Expect=1e-112]} {Dmel: FBgn0038975, Nrx-1, Neurexin 1, [Score=313, Expect=5e-87]} {Celegans: WBGene00007799, nrx-1, NRX-1 beta isoform; NeuReXin related, [Score=179, Expect=2e-45]} {Smed: dd_Smed_v6_13697_0_1, dd_Smed_v6_13697_0_1, [Score=349, Expect=9e-101]} {RNA1509_55888} {RNA1310_9438.1} {RNA815_24775.1} |
| 27. | MligTC455_44050 | 2086 | 43.46 | Mlig455_028045, Mlig455_028051 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.242 Region-specific R2: 6.161 Region-enriched R2: 7.072/0.00000 |
0.98 | - | - | - | 0.980 | - | - | Mlig455_028045 {REF} {Length: 1156} {RNA1509_31459, RNA1509_3903} {RNA1310_2730.2, RNA1509_31459, RNA1509_3903} {RNA1509_31459, RNA1509_3903, RNA815_7682} Mlig455_028051 {REF} {Length: 871} {NoTransDecoderORF} {RNA1509_3903} {RNA1310_15260} {RNA815_7682} |
|
| 28. | MligTC455_26102 | 81 | 1.68 | Mlig455_036981 | Neo: Irradiation Age: logFC(26M/2M)=-0.711 |
0.977 | - | - | - | - | 0.977 | - | Mlig455_036981 {REF} {Length: 2593} {RNA1509_51525} {RNA1310_9237.1} {RNA815_5309} | |
| 29. | MligTC455_28658 | 446 | 9.29 | Mlig455_034539, Mlig455_070435 | Neo: - Age: - |
0.976 | - | - | - | - | - | 0.976 | Mlig455_034539 {REF} {Length: 6257} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF389) [PF04087.16, score=95.9]} {Dmel: FBgn0083945, CG34109, [RH, Score=156, Expect=8e-40]} {Smed: dd_Smed_v6_9934_0_1, dd_Smed_v6_9934_0_1, [RH, Score=148, Expect=5e-38]} {RNA1509_24637} {RNA1310_8899} {RNA815_11179} Mlig455_070435 {REF} {Length: 5153} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF389) [PF04087.16, score=95.3]} {Dmel: FBgn0083945, CG34109, [RH, Score=160, Expect=1e-40]} {Smed: dd_Smed_v6_9934_0_1, dd_Smed_v6_9934_0_1, [RH, Score=151, Expect=1e-38]} {RNA1509_24637} {RNA1310_8899, RNA1509_24637} {RNA1509_24637, RNA815_11179} |
|
| 30. | MligTC455_44390 | 1061 | 22.1 | Mlig455_034325 | Neo: - Age: - Region-specific R2: 4.305 Region-enriched R2: 4.226/0.00000 |
0.976 | - | - | - | 0.976 | - | - | Mlig455_034325 {REF} {Length: 1082} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [RH, Score=65.1, Expect=2e-13]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [Score=42.0, Expect=9e-06]} {RNA1509_11607} {RNA1310_49918} {RNA815_49783} | |
| 31. | MligTC455_20350 | 434 | 9.05 | Mlig455_002780, Mlig455_066934 | Neo: - Age: - Region-enriched R2: 3.513/0.00619 |
SYT12 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_002780 {REF} {Length: 2380} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=207, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=3e-72]} {RNA1310_10982.1} {RNA815_10652.1} Mlig455_066934 {REF} {Length: 2274} {Pfam: C2 domain [PF00168.32, score=69.7]} {Human: ENSG00000173227, SYT12, synaptotagmin 12, [Score=214, Expect=3e-64]} {Mouse: ENSMUSG00000049303, Syt12, synaptotagmin XII, [Score=206, Expect=1e-61]} {Dmel: FBgn0261085, Syt12, Synaptotagmin 12, [Score=182, Expect=3e-50]} {Celegans: WBGene00004921, snt-1, Synaptotagmin-1, [Score=142, Expect=2e-37]} {Smed: dd_Smed_v6_8032_0_1, dd_Smed_v6_8032_0_1, [Score=234, Expect=2e-72]} {RNA1310_10982.1} {RNA815_10652.1} |
| 32. | MligTC455_29622 | 818 | 17.05 | Mlig455_047251, Mlig455_047304 | Neo: - Age: - Region-enriched R2: 2.325/0.00092 Regeneration-downregulated BL: -4.291 Regeneration-depleted BL: -4.291 |
CALM2 | 0.974 | - | - | - | 0.974 | - | - | Mlig455_047251 {REF} {Length: 2133} {Pfam: EF hand [PF00036.34, score=100.9]; EF-hand domain pair [PF13499.8, score=97.6]; EF-hand domain [PF13405.8, score=82.7]; EF-hand domain pair [PF13833.8, score=77.3]; EF hand [PF13202.8, score=73.6]; EF-hand domain [PF14658.8, score=41.0]; Dockerin type I domain [PF00404.20, score=35.2]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=29.7]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=26.5]; Tellurite resistance protein TerB [PF05099.15, score=20.5]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=127, Expect=3e-36]; ENSG00000198668, CALM1, calmodulin 1, [Score=125, Expect=6e-36]; ENSG00000160014, CALM3, calmodulin 3, [Score=125, Expect=7e-36]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=130, Expect=2e-37]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=125, Expect=5e-36]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=125, Expect=5e-36]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=122, Expect=4e-35]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=122, Expect=3e-35]} {Smed: dd_Smed_v6_12048_0_1, dd_Smed_v6_12048_0_1, [RH, Score=166, Expect=8e-50]} {RNA1509_29426} {RNA1310_21067.1} {RNA815_25363} Mlig455_047304 {REF} {Length: 1449} {Pfam: EF hand [PF00036.34, score=101.1]; EF-hand domain pair [PF13499.8, score=95.2]; EF-hand domain pair [PF13833.8, score=81.2]; EF-hand domain [PF13405.8, score=80.9]; EF hand [PF13202.8, score=73.1]; EF-hand domain [PF14658.8, score=40.8]; Dockerin type I domain [PF00404.20, score=34.9]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=30.2]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.0]; Tellurite resistance protein TerB [PF05099.15, score=20.3]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=125, Expect=2e-35]; ENSG00000198668, CALM1, calmodulin 1, [Score=124, Expect=4e-35]; ENSG00000160014, CALM3, calmodulin 3, [Score=123, Expect=4e-35]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=127, Expect=3e-36]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=123, Expect=3e-35]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=123, Expect=3e-35]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=120, Expect=2e-34]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=120, Expect=2e-34]} {Smed: dd_Smed_v6_12048_0_1, dd_Smed_v6_12048_0_1, [RH, Score=162, Expect=6e-48]} {RNA1509_29426} {RNA1310_20874} {RNA815_31458} |
| 33. | MligTC455_47395 | 71 | 1.48 | Mlig455_052211 | Neo: - Age: - |
CHRNA10 | 0.974 | - | - | - | 0.974 | - | - | Mlig455_052211 {REF} {Length: 3367} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=210.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=144.4]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=125, Expect=9e-30]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=125, Expect=6e-30]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=120, Expect=4e-28]} {Dmel: FBgn0015519, nAChRalpha3, nicotinic Acetylcholine Receptor alpha3, [Score=111, Expect=9e-25]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=135, Expect=2e-33]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=123, Expect=3e-29]} {RNA1509_30974} {RNA1310_28768.1} {RNA815_26436} |
| 34. | MligTC455_44391 | 2139 | 44.56 | Mlig455_034381, Mlig455_043867 | Neo: - Age: logFC(26M/2M)=1.551 Region-specific R2: 4.290 Region-enriched R2: 4.082/0.00000 |
0.973 | - | - | - | 0.973 | - | - | Mlig455_034381 {REF} {Length: 1311} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [RH, Score=67.8, Expect=7e-14]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [Score=42.0, Expect=1e-05]} {RNA1509_11607} {RNA1310_49918} {RNA815_49783} Mlig455_043867 {REF} {Length: 1251} {Pfam: Anemonia sulcata toxin III family [PF08098.13, score=19.1]} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [RH, Score=67.4, Expect=5e-14]} {Smed: dd_Smed_v6_1902_0_1, dd_Smed_v6_1902_0_1, [Score=42.0, Expect=1e-05]} {RNA1509_11607} {RNA1310_49918} {RNA815_49783} |
|
| 35. | MligTC455_17040 | 75 | 1.57 | Mlig455_029809 | Neo: - Age: - Region-enriched R7: 3.328/0.01605 |
ARHGAP39 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_029809 {REF} {Length: 3933} {Pfam: MyTH4 domain [PF00784.19, score=92.2]; RhoGAP domain [PF00620.29, score=84.9]} {Human: ENSG00000147799, ARHGAP39, Rho GTPase activating protein 39, [Score=266, Expect=1e-79]} {Mouse: ENSMUSG00000033697, Arhgap39, Rho GTPase activating protein 39, [Score=265, Expect=4e-79]} {Dmel: FBgn0038853, RhoGAP93B, Rho GTPase activating protein at 93B, [Score=221, Expect=1e-63]} {Celegans: WBGene00022365, Y92H12BL.4, [Score=149, Expect=1e-40]} {Smed: dd_Smed_v6_5836_0_1, dd_Smed_v6_5836_0_1, [Score=125, Expect=4e-31]} {RNA1310_44535} {RNA815_34943} |
| 36. | MligTC455_44600 | 1240 | 25.82 | Mlig455_058475 | Neo: - Age: Up-Down-Down |
PLCB4 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_058475 {REF} {Length: 6816} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=202.4]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=142.8]; PH domain [PF17787.3, score=115.5]; Protein of unknown function (DUF1154) [PF06631.13, score=41.8]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=31.0]; C2 domain [PF00168.32, score=22.7]} {Human: ENSG00000101333, PLCB4, phospholipase C beta 4, [RH, Score=1318, Expect=0.0]} {Mouse: ENSMUSG00000039943, Plcb4, phospholipase C, beta 4, [RH, Score=1316, Expect=0.0]} {Dmel: FBgn0262738, norpA, no receptor potential A, [RH, Score=547, Expect=8e-175]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [RH, Score=1145, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=1521, Expect=0.0]} {RNA1509_7348} {RNA1310_5860} {RNA815_5854} |
| 37. | MligTC455_42756 | 115 | 2.39 | Mlig455_059859 | Neo: - Age: Up-Down-Up |
FSCN1 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_059859 {REF} {Length: 2510} {Pfam: Fascin domain [PF06268.15, score=184.5]; FRG1-like domain [PF06229.14, score=76.5]; Ricin-type beta-trefoil lectin domain-like [PF14200.8, score=23.3]; Fibroblast growth factor [PF00167.20, score=21.4]; Domain of unknown function (DUF569) [PF04601.15, score=19.3]} {Human: ENSG00000075618, FSCN1, fascin actin-bundling protein 1, [Score=322, Expect=9e-105]; ENSG00000186765, FSCN2, fascin actin-bundling protein 2, retinal, [Score=308, Expect=3e-99]} {Mouse: ENSMUSG00000029581, Fscn1, fascin actin-bundling protein 1, [Score=317, Expect=1e-102]} {Dmel: FBgn0003447, sn, singed, [RH, Score=326, Expect=2e-106]} {Smed: dd_Smed_v6_996_0_1, dd_Smed_v6_996_0_1, [RH, Score=501, Expect=3e-175]} {RNA1509_53298} {RNA1310_18751.1, RNA1509_53298} {RNA1509_53298, RNA815_14175} |
| 38. | MligTC455_42515 | 1346 | 28.03 | Mlig455_053976 | Neo: - |
PLXDC2 | 0.964 | - | - | - | 0.964 | - | - | Mlig455_053976 {REF} {Length: 2285} {Human: ENSG00000120594, PLXDC2, plexin domain containing 2, [RH, Score=172, Expect=3e-47]; ENSG00000161381, PLXDC1, plexin domain containing 1, [RH, Score=171, Expect=4e-47]} {Mouse: ENSMUSG00000026748, Plxdc2, plexin domain containing 2, [RH, Score=181, Expect=7e-51]; ENSMUSG00000017417, Plxdc1, plexin domain containing 1, [RH, Score=174, Expect=1e-48]} {Dmel: FBgn0028331, l(1)G0289, lethal (1) G0289, [RH, Score=159, Expect=2e-42]} {Celegans: WBGene00007982, pxd-1, PleXin Domain containing, [RH, Score=161, Expect=5e-44]} {Smed: dd_Smed_v6_68203_0_1, dd_Smed_v6_68203_0_1, [RH, Score=94.7, Expect=5e-23]} {RNA1509_4680} {RNA1310_14519.1} {RNA815_6406.1} |
| 39. | MligTC455_26710 | 57107 | 1189.73 | Mlig455_000780, Mlig455_000781 | Neo: - Age: logFC(26M/2M)=-0.460 Region-enriched R2: 4.248/0.00001 |
0.962 | - | - | - | 0.962 | - | - | Mlig455_000780 {REF} {Length: 574} {RNA1509_267} {RNA1310_112043} {RNA815_7257.1} Mlig455_000781 {REF} {Length: 649} {RNA1509_22192, RNA1509_24, RNA1509_2520, RNA1509_267, RNA1509_57785} {RNA1310_112043, RNA1509_22192, RNA1509_24, RNA1509_2520, RNA1509_267, RNA1509_57785} {RNA1509_22192, RNA1509_24, RNA1509_2520, RNA1509_267, RNA1509_57785, RNA815_7257.1} |
|
| 40. | MligTC455_37325 | 21 | 0.45 | Mlig455_053385 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_053385 {REF} {Length: 347} {NoTransDecoderORF} {RNA1509_46225} {RNA1310_43662} | |
| 41. | MligTC455_38175 | 39 | 0.81 | Mlig455_041332, Mlig455_056218 | Neo: - Age: - |
DNAH9 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_041332 {REF} {Length: 11655} {Pfam: Dynein heavy chain, N-terminal region 1 [PF08385.14, score=560.7]; Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=503.4]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=327.1]; AAA domain (dynein-related subfamily) [PF07728.16, score=68.8]; AAA domain [PF13401.8, score=24.4]; P-loop containing dynein motor region [PF12775.9, score=21.7]; AAA domain [PF13238.8, score=21.3]; AAA ATPase domain [PF13191.8, score=19.6]} {Human: ENSG00000007174, DNAH9, dynein axonemal heavy chain 9, [Score=2544, Expect=0.0]; ENSG00000187775, DNAH17, dynein axonemal heavy chain 17, [Score=2525, Expect=0.0]} {Mouse: ENSMUSG00000056752, Dnah9, dynein, axonemal, heavy chain 9, [Score=2547, Expect=0.0]; ENSMUSG00000033987, Dnah17, dynein, axonemal, heavy chain 17, [Score=2516, Expect=0.0]} {Dmel: FBgn0013812, Dhc93AB, Dynein heavy chain at 93AB, [Score=2306, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=573, Expect=8e-167]} {Smed: dd_Smed_v6_3670_0_1, dd_Smed_v6_3670_0_1, [Score=2819, Expect=0.0]} {RNA1509_7397} {RNA1310_128.1} {RNA815_30.1} Mlig455_056218 {REF} {Length: 12040} {Pfam: Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=505.5]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=433.1]; P-loop containing dynein motor region [PF12775.9, score=256.0]; Dynein heavy chain AAA lid domain [PF17852.3, score=97.3]; AAA domain (dynein-related subfamily) [PF07728.16, score=87.1]; AAA domain [PF13401.8, score=29.7]; AAA ATPase domain [PF13191.8, score=29.6]; AAA domain [PF13604.8, score=25.4]; AAA domain [PF13245.8, score=25.3]; Sigma-54 interaction domain [PF00158.28, score=22.2]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=21.7]; AAA domain [PF13238.8, score=20.7]; Sigma-54 interaction domain [PF14532.8, score=19.9]} {Human: ENSG00000007174, DNAH9, dynein axonemal heavy chain 9, [Score=2583, Expect=0.0]; ENSG00000187775, DNAH17, dynein axonemal heavy chain 17, [Score=2573, Expect=0.0]} {Mouse: ENSMUSG00000033987, Dnah17, dynein, axonemal, heavy chain 17, [Score=2600, Expect=0.0]; ENSMUSG00000056752, Dnah9, dynein, axonemal, heavy chain 9, [Score=2590, Expect=0.0]} {Dmel: FBgn0013812, Dhc93AB, Dynein heavy chain at 93AB, [Score=2405, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=632, Expect=0.0]} {Smed: dd_Smed_v6_3670_0_1, dd_Smed_v6_3670_0_1, [Score=2818, Expect=0.0]} {RNA1509_140, RNA1509_15019} {RNA1310_737, RNA1509_15019} {RNA1509_15019, RNA815_30.1} |
| 42. | MligTC455_48428 | 578 | 12.04 | Mlig455_034987, Mlig455_053697, Mlig455_064889 | Neo: - Age: - |
NEO1 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_034987 {REF} {Length: 1449} {Pfam: Immunoglobulin domain [PF13927.8, score=83.0]; Immunoglobulin I-set domain [PF07679.18, score=69.9]; Immunoglobulin domain [PF13895.8, score=59.6]; Immunoglobulin domain [PF00047.27, score=52.1]; Immunoglobulin V-set domain [PF07686.19, score=43.6]; Immunoglobulin domain [PF18452.3, score=26.9]} {Human: ENSG00000067141, NEO1, neogenin 1, [Score=102, Expect=1e-22]; ENSG00000166450, PRTG, protogenin, [Score=97.8, Expect=3e-21]} {Mouse: ENSMUSG00000036030, Prtg, protogenin, [Score=94.4, Expect=3e-20]} {Dmel: FBgn0011592, fra, frazzled, [Score=76.6, Expect=1e-14]} {Celegans: WBGene00004256, pxn-1, Peroxidasin homolog, [Score=51.6, Expect=9e-07]} {Smed: dd_Smed_v6_11123_0_1, dd_Smed_v6_11123_0_1, [Score=59.7, Expect=2e-09]} {RNA1509_18708} {RNA1310_41845} {RNA815_22774} Mlig455_053697 {REF} {Length: 5168} {Pfam: Fibronectin type III domain [PF00041.23, score=164.7]; Immunoglobulin domain [PF13927.8, score=111.6]; Immunoglobulin I-set domain [PF07679.18, score=105.0]; Immunoglobulin domain [PF13895.8, score=85.3]; Immunoglobulin domain [PF00047.27, score=61.8]; Immunoglobulin V-set domain [PF07686.19, score=50.1]; Purple acid Phosphatase, N-terminal domain [PF16656.7, score=41.7]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=26.3]; Immunoglobulin domain [PF18452.3, score=25.2]} {Human: ENSG00000067141, NEO1, neogenin 1, [RH, Score=313, Expect=1e-86]} {Mouse: ENSMUSG00000032340, Neo1, neogenin, [RH, Score=298, Expect=8e-82]} {Dmel: FBgn0011592, fra, frazzled, [RH, Score=242, Expect=2e-64]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=82.8, Expect=2e-15]} {Smed: dd_Smed_v6_11409_0_1, dd_Smed_v6_11409_0_1, [RH, Score=114, Expect=2e-25]} {RNA1509_18708} {RNA1310_6185.1} {RNA815_22774} Mlig455_064889 {REF} {Length: 4838} {Pfam: Fibronectin type III domain [PF00041.23, score=167.9]; Immunoglobulin domain [PF13927.8, score=111.8]; Immunoglobulin I-set domain [PF07679.18, score=105.5]; Immunoglobulin domain [PF13895.8, score=85.9]; Immunoglobulin domain [PF00047.27, score=60.6]; Immunoglobulin V-set domain [PF07686.19, score=50.4]; Purple acid Phosphatase, N-terminal domain [PF16656.7, score=42.6]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=26.5]; Immunoglobulin domain [PF18452.3, score=25.3]; Neuron-derived neurotrophic factor [PF10179.11, score=20.3]} {Human: ENSG00000067141, NEO1, neogenin 1, [RH, Score=311, Expect=5e-86]} {Mouse: ENSMUSG00000032340, Neo1, neogenin, [RH, Score=300, Expect=2e-82]} {Dmel: FBgn0011592, fra, frazzled, [RH, Score=239, Expect=1e-63]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=81.6, Expect=4e-15]} {Smed: dd_Smed_v6_7195_0_1, dd_Smed_v6_7195_0_1, [Score=111, Expect=2e-24]} {RNA1509_18708} {RNA1310_6185.1} {RNA815_22774} |
| 43. | MligTC455_08333 | 172 | 3.59 | Mlig455_025435, Mlig455_025445 | Neo: - Age: - |
TNS1 | 0.96 | - | - | - | - | 0.960 | - | Mlig455_025435 {REF} {Length: 4797} {Pfam: Phosphotyrosine-binding domain [PF08416.15, score=67.1]; C2 domain of PTEN tumour-suppressor protein [PF10409.11, score=38.4]; SH2 domain [PF00017.26, score=36.5]} {Human: ENSG00000079308, TNS1, tensin 1, [RH, Score=257, Expect=2e-69]; ENSG00000136205, TNS3, tensin 3, [RH, Score=251, Expect=1e-67]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [RH, Score=256, Expect=1e-72]; ENSMUSG00000020422, Tns3, tensin 3, [RH, Score=251, Expect=1e-67]} {Dmel: FBgn0000244, by, blistery, [RH, Score=222, Expect=2e-60]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=243, Expect=6e-72]} {Smed: dd_Smed_v6_4454_0_2, dd_Smed_v6_4454_0_2, [Score=217, Expect=5e-59]} {RNA1509_43365} {RNA1310_7714, RNA1509_43365} {RNA1509_43365, RNA815_14514} Mlig455_025445 {REF} {Length: 1758} {Pfam: C2 domain of PTEN tumour-suppressor protein [PF10409.11, score=37.0]} {Human: ENSG00000079308, TNS1, tensin 1, [RH, Score=191, Expect=2e-53]} {Mouse: ENSMUSG00000055322, Tns1, tensin 1, [Score=191, Expect=3e-51]; ENSMUSG00000037003, Tns2, tensin 2, [Score=187, Expect=4e-50]} {Dmel: FBgn0026379, Pten, Phosphatase and tensin homolog, [Score=67.8, Expect=1e-11]} {Celegans: WBGene00006508, tns-1, TeNSin homolog, [Score=109, Expect=1e-24]} {RNA1509_44169} {RNA1310_10509} {RNA815_24170} |
| 44. | MligTC455_18505 | 15 | 0.31 | Mlig455_017536 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_017536 {REF} {Length: 2174} {RNA1310_61282} {RNA815_41334} | |
| 45. | MligTC455_26652 | 30 | 0.63 | Mlig455_036452 | Neo: - Age: - |
NR2E1 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_036452 {REF} {Length: 2848} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=99.9]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=55.3]} {Human: ENSG00000112333, NR2E1, nuclear receptor subfamily 2 group E member 1, [Score=139, Expect=2e-35]} {Mouse: ENSMUSG00000019803, Nr2e1, nuclear receptor subfamily 2, group E, member 1, [Score=139, Expect=1e-35]} {Dmel: FBgn0015381, dsf, dissatisfaction, [Score=129, Expect=6e-31]} {Celegans: WBGene00021417, nhr-236, Nuclear Hormone Receptor family, [RH, Score=135, Expect=1e-35]} {Smed: dd_Smed_v6_25420_0_1, dd_Smed_v6_25420_0_1, [RH, Score=182, Expect=3e-50]} {RNA1310_57853} {RNA815_57699} |
| 46. | MligTC455_31174 | 43 | 0.89 | Mlig455_066686 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_066686 {REF} {Length: 1562} {Pfam: Glycosyltransferase family 92 [PF01697.29, score=108.0]; Glycosyl transferase family 2 [PF13704.8, score=25.6]} {Dmel: FBgn0032506, CG9395, [Score=104, Expect=5e-24]} {Celegans: WBGene00012941, Y47D3B.4, [Score=51.6, Expect=5e-07]} {Smed: dd_Smed_v6_5401_0_1, dd_Smed_v6_5401_0_1, [Score=200, Expect=8e-60]} {RNA1310_16379.1} {RNA815_14941.1} | |
| 47. | MligTC455_50454 | 394 | 8.21 | Mlig455_057487 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.517/0.00000 |
0.959 | - | - | - | 0.959 | - | - | Mlig455_057487 {REF} {Length: 724} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=33.5]; Nematode insulin-related peptide beta type [PF03488.16, score=20.4]} {RNA1509_58074} {RNA1310_51990} {RNA815_25071} | |
| 48. | MligTC455_07327 | 46 | 0.95 | Mlig455_001874, Mlig455_001949 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_001874 {REF} {Length: 1082} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.3]} {Celegans: WBGene00019444, frpr-11, FMRFamide Peptide Receptor family, [Score=47.8, Expect=7e-06]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [Score=57.4, Expect=3e-09]} {RNA1310_94087} {RNA815_48529} Mlig455_001949 {REF} {Length: 2058} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=42.4]} {Smed: dd_Smed_v6_3522_0_1, dd_Smed_v6_3522_0_1, [Score=57.0, Expect=4e-09]} {RNA1509_46461} {RNA1310_94087} {RNA815_57978} |
|
| 49. | MligTC455_24032 | 164 | 3.42 | Mlig455_001002 | Neo: - Age: Up-Down-Down |
DSCAML1 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_001002 {REF} {Length: 8646} {Pfam: Immunoglobulin domain [PF13927.8, score=141.9]; Fibronectin type III domain [PF00041.23, score=127.5]; Immunoglobulin I-set domain [PF07679.18, score=114.8]; Immunoglobulin domain [PF13895.8, score=78.5]; Immunoglobulin domain [PF00047.27, score=75.8]; Immunoglobulin V-set domain [PF07686.19, score=48.9]} {Human: ENSG00000177103, DSCAML1, DS cell adhesion molecule like 1, [Score=140, Expect=3e-32]} {Mouse: ENSMUSG00000032087, Dscaml1, DS cell adhesion molecule like 1, [Score=138, Expect=8e-32]} {Dmel: FBgn0263219, Dscam4, Down syndrome cell adhesion molecule 4, [Score=170, Expect=9e-42]} {Celegans: WBGene00004371, rig-4, Protein sidekick homolog, [Score=86.3, Expect=3e-16]} {Smed: dd_Smed_v6_3024_0_2, dd_Smed_v6_3024_0_2, [Score=287, Expect=2e-77]} {RNA1509_57897, RNA1509_9070} {RNA1310_454.1, RNA1509_57897, RNA1509_9070} {RNA1509_57897, RNA1509_9070, RNA815_227} |
| 50. | MligTC455_34629 | 249 | 5.18 | Mlig455_063855 | Neo: - Age: - |
0.958 | - | - | - | - | - | 0.958 | Mlig455_063855 {REF} {Length: 1672} {RNA1509_9459} {RNA1310_19972.1} {RNA815_11021.1} | |
| 51. | MligTC455_18847 | 5039 | 104.98 | Mlig455_017924 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.933 Region-specific R3: 4.309 Region-enriched R3: 3.414/0.00000 |
0.957 | - | - | - | 0.957 | - | - | Mlig455_017924 {REF} {Length: 1071} {RNA1509_16771, RNA1509_3550} {RNA1310_54908.2, RNA1509_16771, RNA1509_3550} {RNA1509_16771, RNA1509_3550, RNA815_21198.1} | |
| 52. | MligTC455_26118 | 25 | 0.52 | Mlig455_036932 | Neo: - Age: logFC(26M/2M)=0.870 |
0.956 | - | - | - | - | 0.956 | - | Mlig455_036932 {REF} {Length: 2939} {RNA1509_28486} {RNA1310_24343.1} {RNA815_8096} | |
| 53. | MligTC455_45653 | 96 | 2 | Mlig455_010906 | Neo: - Age: - |
0.956 | - | - | - | - | - | 0.956 | Mlig455_010906 {REF} {Length: 1098} {RNA1509_6080} {RNA1310_201.1} {RNA815_6427.2} | |
| 54. | MligTC455_07554 | 24 | 0.51 | Mlig455_027995 | Neo: - Age: - |
GALR2 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_027995 {REF} {Length: 2582} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=33.7]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=49.3, Expect=1e-05]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=59.3, Expect=4e-09]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [RH, Score=184, Expect=9e-53]} |
| 55. | MligTC455_29232 | 131 | 2.72 | Mlig455_050150 | Neo: - Age: - Regeneration-downregulated BL: -4.109 Regeneration-depleted BL: -4.109 |
PCDH9 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_050150 {REF} {Length: 3993} {Pfam: Cadherin domain [PF00028.19, score=289.2]; Cadherin-like [PF08266.14, score=40.2]; Cadherin-like [PF16184.7, score=34.6]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [Score=302, Expect=4e-85]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [RH, Score=307, Expect=1e-86]} {Dmel: FBgn0284247, ds, dachsous, [Score=207, Expect=7e-54]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=169, Expect=3e-42]} {Smed: dd_Smed_v6_21489_0_1, dd_Smed_v6_21489_0_1, [Score=330, Expect=2e-97]} {RNA1310_46914} |
| 56. | MligTC455_17644 | 182 | 3.8 | Mlig455_007930, Mlig455_008033 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_007930 {REF} {Length: 2086} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.9]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=3e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} Mlig455_008033 {REF} {Length: 1974} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.6]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=4e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} |
|
| 57. | MligTC455_24567 | 173 | 3.6 | Mlig455_029270 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.352 Region-enriched R2: 2.683/0.03045 |
PEF1 | 0.954 | - | - | - | - | - | 0.954 | Mlig455_029270 {REF} {Length: 2216} {TRANSSPLICED} {Pfam: EF-hand domain [PF13405.8, score=38.4]; EF hand [PF00036.34, score=36.9]; EF hand [PF13202.8, score=31.7]; EF-hand domain pair [PF13499.8, score=30.5]} {Human: ENSG00000162517, PEF1, penta-EF-hand domain containing 1, [Score=72.8, Expect=6e-15]} {Mouse: ENSMUSG00000028779, Pef1, penta-EF hand domain containing 1, [Score=75.5, Expect=5e-16]} {Smed: dd_Smed_v6_1457_0_1, dd_Smed_v6_1457_0_1, [Score=60.1, Expect=2e-11]} {RNA1509_33230} {RNA1310_42935.1, RNA1509_33230} {RNA1509_33230, RNA815_24745} |
| 58. | MligTC455_41376 | 50 | 1.04 | Mlig455_057140 | Neo: - Age: Up-Down-Up |
EGR1 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_057140 {REF} {Length: 3119} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=51.7]; Zinc-finger double domain [PF13465.8, score=50.3]; C2H2-type zinc finger [PF13894.8, score=38.1]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=23.3]; C2H2-type zinc finger [PF13912.8, score=21.2]} {Human: ENSG00000120738, EGR1, early growth response 1, [Score=159, Expect=3e-42]; ENSG00000179388, EGR3, early growth response 3, [Score=154, Expect=8e-42]} {Mouse: ENSMUSG00000038418, Egr1, early growth response 1, [Score=159, Expect=2e-42]; ENSMUSG00000033730, Egr3, early growth response 3, [Score=154, Expect=6e-42]} {Dmel: FBgn0003499, sr, stripe, [Score=159, Expect=2e-41]} {Celegans: WBGene00043705, egrh-2, EGR (Early Growth factor Response factor) Homolog, [Score=139, Expect=3e-39]} {Smed: dd_Smed_v6_7091_0_1, dd_Smed_v6_7091_0_1, [Score=132, Expect=4e-34]} {RNA1509_44884} {RNA1310_48721} {RNA815_42057} |
| 59. | MligTC455_18311 | 278 | 5.78 | Mlig455_060226 | Neo: - Age: - |
ERBB2 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_060226 {REF} {Length: 3774} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=262.6]; Protein kinase domain [PF00069.27, score=123.0]; Growth factor receptor domain IV [PF14843.8, score=58.3]; Furin-like cysteine rich region [PF00757.22, score=58.0]; Receptor L domain [PF01030.26, score=40.8]} {Human: ENSG00000141736, ERBB2, erb-b2 receptor tyrosine kinase 2, [Score=415, Expect=2e-125]; ENSG00000178568, ERBB4, erb-b2 receptor tyrosine kinase 4, [Score=411, Expect=7e-124]} {Mouse: ENSMUSG00000062209, Erbb4, erb-b2 receptor tyrosine kinase 4, [Score=413, Expect=2e-124]; ENSMUSG00000062312, Erbb2, erb-b2 receptor tyrosine kinase 2, [Score=406, Expect=3e-122]; ENSMUSG00000020122, Egfr, epidermal growth factor receptor, [Score=406, Expect=1e-122]} {Dmel: FBgn0003731, Egfr, Epidermal growth factor receptor, [Score=286, Expect=7e-80]} {Celegans: WBGene00002299, let-23, Receptor tyrosine-protein kinase let-23, [Score=244, Expect=5e-66]} {Smed: dd_Smed_v6_11310_0_1, dd_Smed_v6_11310_0_1, [Score=293, Expect=4e-82]} {RNA1509_22335} {RNA1310_6535, RNA1509_22335} {RNA1509_22335, RNA815_32727} |
| 60. | MligTC455_36990 | 44 | 0.91 | Mlig455_042274 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_042274 {REF} {Length: 1793} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=36.0]; TgpA N-terminal domain [PF11992.10, score=19.0]} {Smed: dd_Smed_v6_24483_0_1, dd_Smed_v6_24483_0_1, [RH, Score=138, Expect=2e-36]} {RNA1310_21197} {RNA815_30263} | |
| 61. | MligTC455_38967 | 71 | 1.48 | Mlig455_060741 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.569 Region-enriched R2: 3.815/0.00926 |
UTRN | 0.953 | - | - | - | - | 0.953 | - | Mlig455_060741 {REF} {Length: 4727} {Pfam: EF-hand [PF09069.13, score=127.4]; EF hand [PF09068.13, score=102.4]; Zinc finger, ZZ type [PF00569.19, score=37.7]; WW domain [PF00397.28, score=18.6]} {Human: ENSG00000152818, UTRN, utrophin, [RH, Score=493, Expect=5e-147]; ENSG00000198947, DMD, dystrophin, [RH, Score=489, Expect=1e-150]} {Mouse: ENSMUSG00000019820, Utrn, utrophin, [RH, Score=493, Expect=2e-156]; ENSMUSG00000045103, Dmd, dystrophin, muscular dystrophy, [RH, Score=487, Expect=3e-145]} {Dmel: FBgn0260003, Dys, Dystrophin, [RH, Score=516, Expect=4e-155]} {Celegans: WBGene00001131, dys-1, Dystrophin-1, [RH, Score=337, Expect=1e-95]} {Smed: dd_Smed_v6_5325_0_6, dd_Smed_v6_5325_0_6, [RH, Score=295, Expect=4e-82]} {RNA1509_38827} {RNA1310_24533} {RNA815_12379} |
| 62. | MligTC455_39991 | 66 | 1.38 | Mlig455_021997 | Neo: - Age: - |
GLRA2 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_021997 {REF} {Length: 3430} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=119.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.5]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=210, Expect=4e-62]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=208, Expect=3e-61]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=207, Expect=6e-61]; ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=202, Expect=2e-59]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=213, Expect=5e-63]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=207, Expect=7e-61]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=206, Expect=9e-61]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=203, Expect=1e-59]} {Dmel: FBgn0024963, GluClalpha, [Score=202, Expect=3e-59]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=196, Expect=7e-57]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [Score=195, Expect=5e-57]} {RNA1310_40572} |
| 63. | MligTC455_52310 | 100 | 2.08 | Mlig455_014082 | Neo: - Age: - Region-enriched R2: 4.038/0.02037 |
0.953 | - | - | - | - | 0.953 | - | Mlig455_014082 {REF} {Length: 1503} {Smed: dd_Smed_v6_12908_0_1, dd_Smed_v6_12908_0_1, [Score=52.4, Expect=1e-08]} {RNA1509_50808} {RNA1310_3413} {RNA815_20403} | |
| 64. | MligTC455_17175 | 78 | 1.62 | Mlig455_042330, Mlig455_047110 | Neo: - Age: - |
GABRA6 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_042330 {REF} {Length: 1845} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=104.1]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=236, Expect=1e-72]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=229, Expect=4e-69]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=241, Expect=9e-75]} {Dmel: FBgn0030707, CG8916, [Score=248, Expect=4e-77]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=227, Expect=2e-69]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=242, Expect=6e-76]} {RNA1310_60750} {RNA815_41846} Mlig455_047110 {REF} {Length: 1843} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=138.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.4]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=248, Expect=4e-76]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=246, Expect=4e-74]; ENSG00000151834, GABRA2, gamma-aminobutyric acid type A receptor alpha2 subunit, [Score=243, Expect=4e-74]; ENSG00000186297, GABRA5, gamma-aminobutyric acid type A receptor alpha5 subunit, [Score=242, Expect=1e-73]; ENSG00000011677, GABRA3, gamma-aminobutyric acid type A receptor alpha3 subunit, [Score=239, Expect=3e-72]; ENSG00000022355, GABRA1, gamma-aminobutyric acid type A receptor alpha1 subunit, [Score=239, Expect=2e-72]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=236, Expect=2e-71]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=254, Expect=1e-78]; ENSMUSG00000029211, Gabra4, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 4, [Score=244, Expect=1e-73]; ENSMUSG00000055078, Gabra5, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5, [Score=244, Expect=1e-74]; ENSMUSG00000000560, Gabra2, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2, [Score=243, Expect=4e-74]} {Dmel: FBgn0030707, CG8916, [Score=268, Expect=2e-83]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=252, Expect=1e-77]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=263, Expect=1e-82]} {RNA1310_60750} {RNA815_41846} |
| 65. | MligTC455_33772 | 104 | 2.17 | Mlig455_016493 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.862/0.00025 |
0.952 | - | - | - | - | 0.952 | - | Mlig455_016493 {REF} {Length: 883} {RNA1310_43848} {RNA815_55624} | |
| 66. | MligTC455_41448 | 192 | 4.01 | Mlig455_066626 | Neo: - Age: - Region-specific R2: 6.449 Region-enriched R2: 4.988/0.02499 |
0.952 | - | - | - | - | 0.952 | - | Mlig455_066626 {REF} {Length: 987} {Pfam: F5/8 type C domain [PF00754.27, score=25.0]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=52.4, Expect=8e-09]} {RNA1509_36923} {RNA1310_37535} {RNA815_20943} | |
| 67. | MligTC455_50186 | 142 | 2.95 | Mlig455_069498 | Neo: - Age: logFC(26M/2M)=-0.479 |
CHRNA10 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_069498 {REF} {Length: 3405} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=107.1]; Immunoglobulin domain [PF13895.8, score=27.7]; Immunoglobulin domain [PF13927.8, score=25.7]; Immunoglobulin I-set domain [PF07679.18, score=25.5]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=110, Expect=5e-25]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=108, Expect=5e-24]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=105, Expect=3e-23]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=105, Expect=3e-23]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=105, Expect=3e-23]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=102, Expect=2e-22]; ENSMUSG00000027950, Chrnb2, cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal), [Score=100, Expect=1e-21]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=119, Expect=3e-27]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=126, Expect=3e-30]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=105, Expect=1e-23]} {RNA1509_43700} {RNA1310_8429} {RNA815_11541} |
| 68. | MligTC455_06838 | 42 | 0.88 | Mlig455_063567 | Neo: - Age: Down-Down-Up |
0.951 | - | - | - | - | 0.951 | - | Mlig455_063567 {REF} {Length: 1509} {RNA1310_26608} | |
| 69. | MligTC455_26517 | 54 | 1.13 | Mlig455_050870, Mlig455_053969 | Neo: - Age: logFC(26M/2M)=-0.514 |
0.951 | - | - | - | - | 0.951 | - | Mlig455_050870 {REF} {Length: 3430} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=54.1]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=32.7]} {Smed: dd_Smed_v6_6819_0_2, dd_Smed_v6_6819_0_2, [Score=152, Expect=9e-42]} {RNA1509_35362} {RNA1310_8376} {RNA815_4529} Mlig455_053969 {REF} {Length: 989} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=74.2]} {Smed: dd_Smed_v6_16441_0_5, dd_Smed_v6_16441_0_5, [Score=51.6, Expect=3e-07]} {RNA1509_35362} {RNA1310_21423.2} {RNA815_13686} |
|
| 70. | MligTC455_27532 | 14 | 0.3 | Mlig455_050096 | Neo: - Age: - |
ITPKA | 0.951 | - | - | - | - | 0.951 | - | Mlig455_050096 {REF} {Length: 2853} {Pfam: Inositol polyphosphate kinase [PF03770.18, score=89.5]} {Human: ENSG00000137825, ITPKA, inositol-trisphosphate 3-kinase A, [Score=206, Expect=4e-60]; ENSG00000143772, ITPKB, inositol-trisphosphate 3-kinase B, [Score=198, Expect=2e-54]} {Mouse: ENSMUSG00000027296, Itpka, inositol 1,4,5-trisphosphate 3-kinase A, [Score=207, Expect=6e-61]; ENSMUSG00000003752, Itpkc, inositol 1,4,5-trisphosphate 3-kinase C, [Score=197, Expect=2e-55]; ENSMUSG00000038855, Itpkb, inositol 1,4,5-trisphosphate 3-kinase B, [Score=197, Expect=4e-54]} {Dmel: FBgn0032147, IP3K1, Inositol 1,4,5-triphosphate kinase 1, [Score=180, Expect=4e-52]} {Celegans: WBGene00002979, lfe-2, Inositol-trisphosphate 3-kinase homolog, [Score=207, Expect=8e-62]} {Smed: dd_Smed_v6_3687_0_2, dd_Smed_v6_3687_0_2, [Score=182, Expect=6e-51]} {RNA1509_15208} {RNA1310_45410.1} {RNA815_8803} |
| 71. | MligTC455_37563 | 45 | 0.94 | Mlig455_025592, Mlig455_057216, Mlig455_060662 | Neo: - Age: Up-Down-Up |
GALR2, OPN4, TRHR | 0.951 | - | - | - | - | 0.951 | - | Mlig455_025592 {REF} {Length: 4246} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=86.7]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=77.2]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=58.5, Expect=8e-09]; ENSG00000174417, TRHR, thyrotropin releasing hormone receptor, [Score=57.8, Expect=1e-08]} {Mouse: ENSMUSG00000026237, Nmur1, neuromedin U receptor 1, [Score=57.8, Expect=9e-09]; ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=55.8, Expect=3e-08]} {Dmel: FBgn0038874, ETHR, [Score=86.7, Expect=3e-18]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=93.6, Expect=1e-20]} {Smed: dd_Smed_v6_16149_0_1, dd_Smed_v6_16149_0_1, [RH, Score=164, Expect=2e-47]} {RNA1509_10419} {RNA1310_74041} {RNA815_44148} Mlig455_057216 {REF} {Length: 2773} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=87.0]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=77.5]} {Human: ENSG00000174417, TRHR, thyrotropin releasing hormone receptor, [Score=57.0, Expect=2e-08]; ENSG00000182687, GALR2, galanin receptor 2, [Score=55.5, Expect=6e-08]} {Mouse: ENSMUSG00000026237, Nmur1, neuromedin U receptor 1, [Score=57.8, Expect=7e-09]} {Dmel: FBgn0038874, ETHR, [Score=86.3, Expect=3e-18]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=92.0, Expect=2e-20]} {Smed: dd_Smed_v6_16149_0_1, dd_Smed_v6_16149_0_1, [RH, Score=162, Expect=7e-47]} {RNA1509_50426} {RNA1310_74041} {RNA815_44148} Mlig455_060662 {REF} {Length: 1185} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=76.7]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=67.1]} {Human: ENSG00000122375, OPN4, opsin 4, [Score=50.4, Expect=3e-06]; ENSG00000174417, TRHR, thyrotropin releasing hormone receptor, [Score=48.9, Expect=7e-06]} {Dmel: FBgn0029723, Proc-R, Proctolin receptor, [Score=73.9, Expect=4e-14]} {Celegans: WBGene00020586, frpr-18, FLP-2 receptor; FMRFamide Peptide Receptor family, [Score=77.0, Expect=3e-15]} {Smed: dd_Smed_v6_16149_0_1, dd_Smed_v6_16149_0_1, [Score=144, Expect=6e-40]} {RNA1310_74041} {RNA815_42171} |
| 72. | MligTC455_42057 | 167 | 3.48 | Mlig455_003225 | Neo: - Age: - Region-enriched R2: 6.187/0.00004 |
0.951 | - | - | - | 0.951 | - | - | Mlig455_003225 {REF} {Length: 943} {Pfam: Immunoreceptor tyrosine-based activation motif [PF02189.17, score=79.6]} {RNA1310_57787} {RNA815_49158} | |
| 73. | MligTC455_43272 | 467 | 9.73 | Mlig455_007706, Mlig455_021038 | Neo: - Age: - Region-enriched R4: 2.849/0.04948 Regeneration-upregulated BL: 3.619 Regeneration-enriched BL: 3.619 |
0.95 | - | - | - | - | 0.950 | - | Mlig455_007706 {REF} {Length: 2491} {Pfam: Galactose binding lectin domain [PF02140.20, score=41.5]} {RNA1509_51594} {RNA1310_25581} {RNA815_37571} Mlig455_021038 {REF} {Length: 3071} {Pfam: Galactose binding lectin domain [PF02140.20, score=41.6]} {RNA1509_51594} {RNA1310_25581, RNA1509_51594} {RNA1509_51594, RNA815_37571} |